Replies to post #93887 on Biotech Values

[its_the_oxygen]

That company's stock went crazy in 2003. I rode it for a while and fortunately got out with a very nice gain. Nothing ever came of the trials even though the stock made a significant move on some data out of Mexico city with Squalamine for AMD. I sometimes wonder to this day if that data was a sham or not. They were never able to duplicate the same vision improvements in US trials. Hmmmm. I guess it was because they are now out of business.

[AlpineBV_Miller]

Probably. This field is pretty well littered with off-the-wall types.